Table 1.
Characteristics distribution of subjects
| Total valid N | No MACE (n=171) | MACE (n=31) | P-value | |
|---|---|---|---|---|
| Age (years) | 202 | 62.87±10.81 | 64.29±10.34 | 0.499 |
| Gender | 202 | 0.366 | ||
| Female | 37 (21.64%) | 9 (29.03%) | ||
| Male | 134 (78.36%) | 22 (70.97%) | ||
| proBNP | 195 | 161.25 (67.71-524.23) | 234.1 (82.18-634.1) | 0.119 |
| LDL | 182 | 2.76 (2.14-3.47) | 2.64 (2.22-3.02) | 0.389 |
| SBP (mmHg) | 202 | 130 (117-140) | 128 (116-135) | 0.554 |
| DBP (mmHg) | 202 | 75 (67-82) | 78 (64-89) | 0.76 |
| HR | 202 | 75 (68-80) | 78 (68-83) | 0.294 |
| BMI (kg/m2) | 202 | 24.42±2.86 | 25.44±3.81 | 0.164 |
| Anterior MI | 201 | 0.376 | ||
| No | 133 (78.24%) | 22 (70.97%) | ||
| Yes | 37 (21.76%) | 9 (29.03%) | ||
| Killip gradea | 202 | 0.061 | ||
| I | 160 (93.57%) | 26 (83.87%) | ||
| II | 8 (4.68%) | 3 (9.68%) | ||
| III | 3 (1.75%) | 1 (3.23%) | ||
| IV | 0 (0%) | 1 (3.23%) | ||
| Smoker | 200 | 0.801 | ||
| No | 75 (44.38%) | 13 (41.94%) | ||
| Yes | 94 (55.62%) | 18 (58.06%) | ||
| ACEI/ARB | 202 | 0.198 | ||
| No | 37 (21.64%) | 10 (32.26%) | ||
| Yes | 134 (78.36%) | 21 (67.74%) | ||
| β-blocker | 202 | 0.034 | ||
| No | 22 (12.87%) | 0 (0%) | ||
| Yes | 149 (87.13%) | 31 (100%) | ||
| Statinsa | 202 | 1 | ||
| No | 3 (1.75%) | 0 (0%) | ||
| Yes | 168 (98.25%) | 31 (100%) | ||
| Hypertension | 202 | 0.022 | ||
| No | 70 (40.94%) | 6 (19.35%) | ||
| Yes | 101 (59.06%) | 25 (80.65%) | ||
| Diabetes | 202 | 0.378 | ||
| No | 119 (69.59%) | 24 (77.42%) | ||
| Yes | 52 (30.41%) | 7 (22.58%) | ||
| HRT-TO | 110 | -1.08 (-2.48-0) | -0.84 (-1.24-1.04) | 0.2 |
| HRT-TS | 110 | 5.05 (2.45-8.08) | 5.3 (2.35-8.03) | 0.943 |
| HRV (SDNN) | 167 | 108.64±30.54 | 93.68±31.17 | 0.034 |
| TWA | 99 | 45.5 (39-66.75) | 59 (48-64) | 0.184 |
| VLP | 151 | < 0.001 | ||
| Negative | 121 (70.76%) | 8 (25.81%) | ||
| Positive | 14 (8.19%) | 8 (25.81%) | ||
| VLP-fQRSd | 151 | 87 (80-92) | 92.5 (82-117.75) | 0.031 |
| VLP-RMS (40) | 151 | 28.9 (23.7-39.85) | 27.95 (18.03-36.1) | 0.269 |
| VLP-LAS (40) | 151 | 30 (24-34) | 32.5 (26.75-45.5) | 0.039 |
| LVEF (admission status) | 178 | 61 (57-64) | 59 (55.75-63) | 0.24 |
| LVEF (follow-up) | 180 | 62 (59-64) | 56 (51-64) | 0.002 |
a
Analyzed by Fisher exact test for group comparison.
Continuous variables without normal distribution are presented as median and inter-quartile range (IQR), and Mann-Whitney tests used for group comparisons; continuous variables with normal distribution are presented as mean and standard deviation (SD) and independent t tests used for group comparisons. Categorical variables are presented as counts and percentages. Chi-square tests or Fisher exact tests were applied for comparisons.